retatrutide how to get online with a Clinical Trial Retatrutide, an investigational triple hormone
Description
The outcome can be approval, a Complete Response Letter (requesting more information), or rejection
Among the 256 patients who received GLP-1 RAs, the incidence of osteoporosis was significantly lower than in those who did not receive GLP-1 RAs (P 0.05)
Furthermore, cardiac arrhythmias occurred in 4-14% and 2-3% in the retatrutide groups and placebo group, respectively in the 2 trials [3,4]
Welcome to the GLP-1 skin effect
